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Abstract
Background: The Werner protein (WRN), defective in the premature aging disorder Werner syndrome, participates in a
number of DNA metabolic processes, and we have been interested in the possible regulation of its function in DNA repair
by post-translational modifications. Acetylation mediated by histone acetyltransferases is of key interest because of its
potential importance in aging, DNA repair and transcription.
Methodology/Principal Findings: Here, we have investigated the p300 acetylation mediated changes on the function of
WRN in base excision DNA repair (BER). We show that acetylation of WRN increases in cells treated with methyl
methanesulfonate (MMS), suggesting that acetylation of WRN may play a role in response to DNA damage. This hypothesis
is consistent with our findings that acetylation of WRN stimulates its catalytic activities in vitro and in vivo, and that
acetylated WRN enhances pol b-mediated strand displacement DNA synthesis more than unacetylated WRN. Furthermore,
we show that cellular exposure to the histone deacetylase inhibitor sodium butyrate stimulates long patch BER in wild type
cells but not in WRN depleted cells, suggesting that acetylated WRN participates significantly in this process.
Conclusion/Significance: Collectively, these results provide the first evidence for a specific role of p300 mediated WRN
acetylation in regulating its function during BER.
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Introduction
In eukaryotes, DNA is packaged into highly structured
chromatin filaments, which are further compacted into chromo-
somes. The structure of eukaryotic chromatin and chromosomes
influences accessibility of proteins and multi-protein machines to
eukaryotic DNA, thereby influencing the efficiency and timing of
DNA metabolic processes such as transcription, replication, DNA
repair and recombination. Post-translational modification of
chromatin proteins, including histones, plays a crucial role in
regulating these metabolic processes [1,2]. For example, acetyla-
tion of N-terminal lysine residues generates a more open and
accessible chromatin configuration [3–5] and is associated with
increased gene expression. Histone acetylation is catalyzed by
histone acetyltransferases (HATs) such as p300/CBP and PCAF.
p300 also acetylates several DNA repair proteins [6–9] and
transcriptional regulators [10]. Acetylation of histones and other
non-histone proteins is reversed by histone deacetylases (HDACs);
thus, HATs and HDACs coordinately regulate acetylation status
[11]. Hyperacetylation of histones H3 and H4 enhances DNA
excision repair in UV-irradiated cells, suggesting that the extent of
chromatin acetylation modulates DNA repair [12–15]. The class
III HDAC protein, sir2, prolongs life span in yeast by locking
chromatin into a silent state [16]. Recently, Mostoslavsky et al.
[17] suggested that inactivation of another sirtuins, SIRT6, causes
genome instability and premature aging in mice by inhibiting base
excision repair (BER).
Werner syndrome (WS) is an autosomal recessive segmental
progeria caused by mutations in the gene encoding Werner
protein (WRN). WS patients prematurely develop atrophic skin,
thin gray hair, osteoporosis, type II diabetes, cataracts, arterio-
sclerosis, and cancer [18,19], symptoms that are highly reminis-
cent of normal aging. WRN belongs to the RecQ family of DNA
helicases and has 39-59 helicase and exonuclease activities. WRN
plays a role in maintaining genomic stability, and may play a role
in DNA repair [20]. Several studies correlate WS with a defect in
repair of oxidative DNA damage [21–25], which may directly
contribute to the phenotype of premature aging observed in WS
patients. This idea is consistent with the fact that WRN stimulates
polymerase b (pol b)-mediated DNA synthesis [22,26], an essential
step in BER. However, the exact physiological role of WRN in
DNA metabolism, including BER, is still unclear.
A key element in understanding the function of WRN in DNA
repair may be its post-translational modifications. We have
previously observed that WRN catalytic activities are severely
modified by its phosphorylation status [27,28]. Both serine/
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helicase and exonuclease activities, and may stimulate transloca-
tion of WRN from the nucleolus to sites of DNA damage [27,28].
Acetylation of WRN by p300 also stimulates translocation of
WRN from the nucleolus to the nucleoplasm [29]. However, the
consequences of altered subcellular localization, and the functional
effects of phosphorylation or acetylation of WRN are not yet
known.
Recent studies have demonstrated that p300 acetylates BER
proteins including pol b, 8-oxoguanine-DNA glycosylase 1
(OGG1), and NEIL2 (a glycosylase for oxidized pyrimidines)
[6,7,9], and that acetylation of these proteins affects their functions
differentially. For example, acetylation of pol b specifically inhibits
its dRP lyase activity, but has no effect on its polymerase or AP-
lyase activities [9]. In addition, acetylation by p300 inhibits the
glycosylase activity of human NEIL2 [6] while it stimulates the
glycosylase activity of OGG1, suggesting that OGG1 acetylation
might be important for removal/repair of 8-oxoG and other
damaged bases [7]. Despite much work in this area, the extent to
which acetylation regulates BER is still poorly understood.
In this study, we have examined the role of p300 acetylation in
regulating WRN functions in the context of BER. The results
show that acetylation of WRN by p300 stimulates WRN ATPase,
helicase and exonuclease activities in vitro and in vivo. The level of
WRN acetylation increases in cells exposed to methyl methane-
sulfonate (MMS), and long-patch BER activity increases in wild
type but not in WRN knockdown cells treated with sodium
butyrate. Acetylation of WRN also stimulates pol b-mediated
strand displacement DNA synthesis. These results are consistent
with the hypotheses that acetylation regulates an early step in
response to DNA damage for which, WRN may be an important
immediate downstream target of p300, and that acetylation of
WRN contributes to the regulation of BER.
Results
Acetylation of WRN in vivo is stimulated by MMS
To determine the physiological conditions under which WRN
are acetylated in cells, we transiently transfected 293T cells with
WRN expression plasmid alone or together with p300 expression
plasmid. Acetylated proteins were radiolabeled in vivo by
incubating the cells with 1 mCi/ml [
3H]sodium acetate (Fig. 1A,
upper panel) or 0.5 mCi/ml [
3H]sodium acetate (Figs. 1B–E)
under conditions with or without treatments with 20 J/m
2 UV,
250 mMH 2O2, 1 mM MMS, c-irradiation (6 Gy) or 0.1 mg/ml
psoralen+UVA. The acetylation status of WRN was then analyzed
by autoradiography after immunoprecipitations of WRN with the
anti-WRN antibody. As shown in Fig. 1A (upper panel), lane 1,
the immunoprecipitated WRN was specifically labeled in the
presence of [
3H]sodium acetate, implying that it is acetylated in
vivo. Co-transfection of WRN with p300 revealed a 6-fold increase
in WRN acetylation (compare lanes 1 and 2) indicating that p300
contributes to WRN acetylation in vivo. In addition, the
accumulation of acetylated WRN was found to be time-
dependent. As shown in Fig. 1C, upper panel, lane 1, acetylation
of WRN was detected at 1 h after addition of [
3H]sodium acetate
and the level of [
3H]acetate labeled WRN had increased
significantly at 4 h (Fig. 1C, upper panel, lane 5).
We found that MMS treatment of the cells for 1 h increased the
acetylation of WRN approximately 2-fold compared to untreated
cells (Fig. 1A, upper panel, compare lanes 2 and 5, and Fig. 1B, left
panel, compare lanes 1 and 3). Moreover, 1 mM MMS treatment
further increased the acetylation of WRN after 4 h compared to
MMS treatment at 1 h and untreated cells (Fig. 1B, left panel,
compare lanes 2 and 3 and lanes 1 and 2, respectively). This effect
was not due to an increase in the amount of immunoprecipitated
WRN, because the coomassie staining of the gel before
autoradiography and Western analysis of acetylated samples with
anti-WRN antibody indicated that the same amount of WRN was
immunoprecipitated (Fig. 1A, medium and lower panels, compare
lanes 2 and 5, and Fig. 1B, left panel, lanes 1–3). We also showed
that MMS enhances the acetylation of WRN in the cells
expressing endogenous p300 only (Fig. 1B, right panel). Treatment
of the cells with UV (Fig. 1A, upper panel, lane 3), H2O2 (Fig. 1A,
upper panel, lane 4 and Fig. 1C, upper panel, lanes 2 and 6), c-
irradiation (Fig. 1C, upper panel, lanes 3 and 7) and psorale-
n+UVA (Fig. 1C, upper panel, lanes 4 and 9) did not increase
p300 acetylation of WRN. On the basis of coomassie staining of
the gel before autoradiography (Fig. 1C, medium panel) and
Western blot analysis of the same acetylated samples (lower panel),
the protein levels of WRN were quite similar among the loaded
samples. The incubation of the cells with 250 mMH 2O2 for 1 h,
and associated acetylation of WRN for 1 h and 4 hrs, showed that
under these conditions WRN acetylation decreased (Fig. 1A,
upper panel, lane 4 and Fig. 1C, upper panel, lanes 2 and 6). To
rule out the possibility that we were detecting a phenomenon
caused by cell toxicity or overdose, we conducted an experiment
lowering H2O2 concentration to 50 mM. While 200 mMH 2O2
caused a decrease in the WRN acetylation (Fig. 1D, upper panel,
lane 3), we found that using 50 mMH 2O2 the acetylation status of
WRN did not change (Fig. 1D, upper panel, compare lanes 1 and
2). Fig. 1D, lower panel, shows the Western analysis of the same
acetylated samples. Taken together, these results indicate that
WRN is acetylated in vivo by p300 and that the acetylation is most
prominent after MMS treatment.
To assess whether p300-induced WRN acetylation is directly
mediated by p300, we suppressed p300 expression by p300 siRNA
knockdown in 293T cells transfected with a WRN expression
vector, and measured WRN acetylation with autoradiography as
described above. As shown in Fig. 1E (upper panel), over-
expression of p300 led to augmented acetylation of WRN
(compare lanes 1 and 3), whereas suppression of endogenous
p300 siRNA reduced WRN acetylation (compare lane 2 with lanes
1 and 3). WRN acetylation was detected in cells transfected with
WRN expression vector but not in mock-transfected cells
(compare lanes 1, 3 and 4). Fig. 1E, panels 2 and 3, shows
relative levels of WRN and p300 protein expression. Western
analysis of these cell lysates showed the reduced expression of
endogenous p300 by p300 siRNA in 293T cells (Fig. 1E, panel 3,
compare lane 2 with 1 and 4). Actin was used as a loading control
(Fig. 1E, bottom panel). These results confirm that WRN
acetylation in vivo is mediated by p300.
WRN is acetylated in vitro by p300 and the acetylation
sites are located at the N- and C-terminal domains
We examined in vitro acetylation of WRN by incubating 1 mgo f
WRN with [
14C]acetyl CoA and 100 ng of recombinant human
p300 for 60 min at 30uC. The reaction products were run on a
SDS-PAGE gel and [
14C]-acetate incorporation of WRN was
analyzed by autoradiography. As shown in Fig. 2B, WRN was
labeled by [
14C]acetyl CoA in the presence of p300 in vitro (Fig. 2B,
upper panel, lane 4). This in vitro acetylation was not due to WRN
autoacetylation or nonspecific interaction between WRN and
[
14C]acetyl CoA (Fig. 2B, upper panel, lanes 1–3).
Using a series of recombinant truncated WRN variants (Fig. 2A),
we mapped the p300-dependent acetylation sites of WRN in vitro
to the N-terminal (aa 1–368) (Fig. 2B, upper panel, lane 6) and C-
terminal (aa 949–1432) domains of WRN (Fig. 2C, upper panel,
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terminal domain was further sub-fractioned into two regions
including the RQC (aa 949–1092) or the HRDC and C-terminal
NLS domains (aa 1072–1432) (Fig. 2A). The WRN acetylation site
enacted by p300 resided within a region of WRN that harbors the
HRDC and C-terminal NLS domains (aa 1072–1432) (Fig. 2C,
upper panel, lane 8). The WRN fragments together with acetyl
CoA were used for in vitro acetylation to determine if there were
nonspecific interactions between acetyl CoA and these fragments
or if there was autoacetylation of the fragments (Fig. 2B, upper
panel, lanes 5, 7 and 9; Fig. 2C, upper panel, lanes 3, 5, and 7).
Since the WRN fragments were GST-tagged (Fig. 2A), GST was
used in the acetylation reaction and as shown in Fig. 2C, lane 2
(upper panel), GST was not acetylated by p300. Figs. 2B and 2C
(lower panels) show a coomassie-blue stained SDS-PAGE gel of
the purified WRN and GST-WRN fragments after the acetylation
assay, which was subsequently analyzed using autoradiography
(upper panel).
Acetylation of WRN increases its catalytic activities
To gain further insight into the functional significance of p300-
mediated acetylation of WRN, we investigated whether acetylation
affects the catalytic activities of WRN. Purified WRN was
acetylated in vitro by p300 either in the presence (Fig. 3A, lower
Figure 1. WRN is acetylated in vivo and it is stimulated by MMS treatment. (A) WRN was transiently overexpressed in 293T cells either alone
or together with p300. 48 h after transfection, untreated, UV, H2O2 or MMS treated cells were labeled with 1 mCi/ml [
3H]sodium acetate for 1 h.
[
3H]acetate labeled WRN was immunoprecipitated using an anti-WRN antibody and the complex was resolved on SDS-PAGE and was analyzed either
by autoradiography (upper panel) or Western analysis (lower panel) or coomassie-stained gel after the acetylation assay, which was subsequently,
analyzed using autoradiography (middle panel). (B) Right and left top panels: 48 h after transfection, the cells were treated with 1 mM MMS and WRN
acetylation was followed for 1 h and 4 h (left panel) or 1 h (right panel), and labeled with 0.5 mCi/ml [
3H]sodium acetate for 1 h. [
3H]acetate labeled
WRN was immunoprecipitated using an anti-WRN antibody and the complex was resolved on SDS-PAGE and analyzed by autoradiography. Lower
panels: Western analysis of acetylated samples with an anti-WRN antibody. (C) Top panel: 48 h after transfection, the cells were treated with H2O2 (1
and 4 h), c-irradiation (1 and 4 h) or psoralen+UVA (1 and 16 h) and labeled with 0.5 mCi/ml [
3H]sodium acetate for 1 h. [
3H]acetate labeled WRN was
immunoprecipitated using an anti-WRN antibody and the complex was resolved on SDS-PAGE and analyzed by autoradiography. Medium panel: the
coomassie staining of the gel before autoradiography. Lower panel: Western analysis of acetylated samples with an anti-WRN antibody. (D) Top
panel: After transfection, the cells were treated with 50 mM and 200 mMH 2O2 and labeled with 0.5 mCi/ml [
3H]sodium acetate for 1 h. Lower panel:
Western analysis of acetylated samples with an anti-WRN antibody. (E) 293T cells were transiently transfected with expression vectors of WRN (lanes
1–3), p300 (lane 3), siRNA of p300 (lane 2) or siRNA negative control (lanes 1 and 4) individually or in combination. [
3H]acetate labeled WRN was
immunoprecipitated using an anti-WRN antibody and the complex was resolved on SDS-PAGE and was analyzed either by autoradiography (first
panel) or Western analysis (second panel). Two bottom panels are Western analysis of these cell lysates with anti-p300 and anti-b-Actin antibodies,
which shows relative protein expression levels.
doi:10.1371/journal.pone.0001918.g001
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or WRN alone (lane 4 or 1) for 60 min at 30uC as described
above. The reaction products were analyzed by Western analysis
using an anti-WRN antibody. The results showed that there were
equal amounts of WRN in each reaction (Fig. 3A, upper panel,
lanes 1–5). Analysis of the same blot by anti-acetyl-lysine antibody
showed that WRN was acetylated only in the reaction containing
both p300 and acetyl CoA (Fig. 3A, lower panel, lane 2). These
reaction mixtures were then used to measure WRN ATPase,
helicase, exonuclease and DNA binding activities.
First, we examined the effect of acetylation on the ATPase
activity of WRN. WRN DNA-dependent ATPase activity was
measured by incubating increasing concentrations of acetylated or
unacetylated WRN (15, 45, 90 and 135 nM) with circular
M13mp18 ssDNA and c-[
32P]ATP. The fraction of hydrolyzed
ATP increased with increasing unacetylated WRN (Fig. 3B, open
circles). However, the rate of ATP hydrolysis was significantly
higher (2.5 fold) at all WRN concentrations when the reaction was
performed using acetylated WRN (Fig. 3B, closed circles).
Although acetyl CoA alone did not stimulate WRN ATPase
activity (Fig. 3B, open triangles), the presence of p300 weakly
stimulated WRN ATPase activity even in the absence of acetyl
CoA (Fig. 3B, closed triangles). These results show that p300
acetylation of WRN increases its ATPase activity.
Next, we used a 22 bp forked duplex substrate (Fig. 3C) [30] to
determine whether acetylation of WRN affects its helicase activity.
WRN helicase activity increased with increasing concentration of
unacetylated WRN (Fig. 3C, lanes 12–14) or acetylated WRN
(Fig. 3C, lanes 3–5), but was significantly higher in the presence of
acetylated WRN. At the highest concentration of WRN,
acetylation stimulated WRN helicase activity approximately 4.3-
fold (Fig. 3C, lanes 5 and 14). Although acetyl CoA alone did not
stimulate WRN helicase activity (Fig. 3C, lanes 6–8), p300
stimulated WRN helicase activity by 2-fold at the highest WRN
concentration even in the absence of acetyl CoA (Fig. 3C, lanes 11
and 14). The ability of p300 to stimulate WRN helicase activity
was heat labile (lane 15), suggesting that it is likely intrinsic to the
p300 protein. Furthermore, p300 alone did not unwind the
substrate (data not shown), indicated that p300 does not have an
inherent helicase activity nor does the p300 protein preparation
contain contaminating DNA unwinding activity. Acetylation by
p300 also stimulated WRN exonuclease activity significantly
(Fig. 3D, lanes 2–5); p300 also stimulated WRN exonuclease,
but the stimulation was significantly higher in the presence of
Figure 2. Mapping of the WRN acetylation site. (A) Schematic representation of functional domains of WRN and GST-tagged WRN fragments.
RQC, RecQ-conserved domain; NTS, nucleolar targeting sequence; HRDC, helicase and RNase D conserved domain; NLS, nuclear localization signal.
Numbers indicate WRN amino acid sequence. (B) One microgram of WRN and WRN fragments were incubated with [
14C]-acetyl-CoA in the presence
or absence of p300. The lower panel shows a coomassie-stained SDS-PAGE gel of purified WRN and GST-WRN fragments after the acetylation assay,
which was subsequently, analyzed using autoradiography (top panel). (C) One microgram of GST (control) and GST-WRN fragments were incubated
with [
14C]-acetyl-CoA in the presence or absence of p300. The lower panel shows a coomassie-stained SDS-PAGE gel purified GST-WRN fragments
after the acetylation assay that was analyzed using autoradiography (top panel).
doi:10.1371/journal.pone.0001918.g002
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These results demonstrate that acetylation of WRN by p300
strongly stimulates WRN catalytic activities, while p300 alone
moderately stimulates WRN catalytic activities, independent of its
ability to acetylate WRN protein.
Acetylation enhances the exonuclease activity of WRN in
vivo
To investigate the potential roles for acetylated WRN in cells,
we measured exonuclease activity in WRN immunocomplexes
from 293T cells transfected with WRN expression plasmid alone
or together with the p300 expression plasmid. The washed anti-
IgG or anti-WRN immuno-precipitates were incubated with the
exonuclease substrate. Fig. 4B shows that the anti-WRN
immunoprecipitates digested the 34-bp forked duplex substrate,
and that the digestion was enhanced after the transfection of cells
with p300 (Fig. 4B), which caused the acetylation of WRN
(Fig. 4A). These results suggest that WRN acetylation increased
the exonuclease activity in the WRN complex in vivo.
WRN forms a complex with p300 and p300 interacts with
the acidic domain of WRN (WRN239–499)
To examine whether p300 is in complex with WRN in vivo,w e
performed co-immuno-precipitation experiments using HeLa
nuclear extracts, which were pre-treated with the endonuclease
DNase I. The incubation of the extracts with an antibody against
Figure 3. Effect of acetylation on WRN catalytic activities. (A) One microgram of WRN was incubated with in the presence or absence of acetyl
CoA or p300 or both. The top panel shows a WB of WRN after the acetylation assay, which was stripped and analyzed using anti-acetyl lysine
antibody (bottom panel). These reaction mixtures were used in the measurement of WRN ATPase (B), helicase (C) and exonuclease activities (D). (B)
Acetylation increases the ATPase activity of WRN. [
32P]ATP and 150 ng of M13mp18 ssDNA was incubated with increasing concentrations of
nonacetylated (open circles) and acetylated WRN (closed circles) (15, 45, 90, 135 nM). WRN was incubated with p300 (closed triangles) or with acetyl
CoA (open triangles). ATP hydrolysis was analyzed on PEI-TLC plates developed in 1 M formic acid/0.8 M LiCl. Plates were scanned using a
PhosphorImager. The percentage of ATP hydrolysis was determined by each sample using the ImageQuant software and subtracting background
value in control having no enzyme. (C) The effect of acetylation on WRN helicase activity. Reactions containing increasing amounts (0.125 nM,
0.25 nM and 0.5 nM) of nonacetylated WRN (lanes 12 to 14) and acetylated WRN (lanes 3 to 5) were incubated with a 22 bp forked substrate (0.5 nM,
22Fork3/22Fork4) for 15 min at 37uC. Lanes 6 to 8, WRN in the presence of acetyl CoA. Lanes 9 to 11, WRN in the presence of p300. Lane 1, substrate
only. Lane 2, heat-denatured substrate. Reaction products were run on a 12% native gel and visualized using a PhosphorImager. %D, percentage of
single-stranded product displaced. (D) The effect of WRN acetylation on WRN exonuclease activity. Reactions contained 10 and 20 nM nonacetylated
WRN (lanes 4–5) and acetylated WRN (lanes 2–3), and WRN plus p300 (lanes 6–7) were incubated with a 34 bp forked substrate (0.5 nM, 34ForkA/
34ForkB) for 15 min at 37uC. Lane 1, no enzyme. Products were heat-denatured for 5 min at 95uC, run on a 14% denaturing polyacrylamide gel and
visualized using a PhosphorImager.
doi:10.1371/journal.pone.0001918.g003
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expected (Fig. 5A, bottom panel, lane 3), and also co-precipitated
endogenous p300 (Fig. 5A, upper panel, lane 3). This result was
confirmed by a reciprocal co-immunoprecipitation experiment, in
which antibody to p300 co-immuno-precipitated endogenous
p300 and WRN (Fig. 5B, upper panel, lane 3). Control
experiments showed that pre-immune IgG did not immunopre-
cipitate p300 or WRN (Fig. 5A, upper panel, lane 2 and Fig. 5B,
upper panel, lane 1). These results demonstrate that WRN forms a
complex with p300 in vivo. DNase I degrades exposed DNA,
potentially breaking the tether between two DNA-bound proteins,
but does not intercalate and unwinds the DNA. To ascertain that
the interaction between WRN and p300 was not mediated by
DNA, WRN and p300 were co-immunoprecipitated from HeLa
nuclear extracts pre-treated with or without ethidium bromide
(EtBr), which disrupts non-specific DNA2protein interactions by
intercalating and unwinding the DNA helix (Fig. 5C). The
presence of EtBr did not disrupt the co-precipitation of WRN and
p300 (Fig. 5C, compare lanes 3 and 4). Instead, disruption of the
DNA binding increased the immunoprecipitation of WRN
(Fig. 5C, bottom panel, lane 3) and consequently its co-
immunoprecipitation with p300 (upper panel, lane 3). This may
be due to the release of WRN or p300 from DNA, allowing them
to associate more readily. Since WRN forms a complex with p300
in the presence of EtBr (Fig. 5C, upper panel, lane2), it can be
concluded that this protein-protein interaction is not mediated by
DNA. Furthermore, ELISA experiments also suggest that WRN
and p300 interact directly (Fig. S1).
The region of WRN that interacts physically with p300 was
mapped using GST-tagged fragments of recombinant WRN and
analyzing which of these fragments retain the ability to bind p300.
GST fusion proteins were bound to glutathione beads, and mixed
with HeLa nuclear extracts in the presence of DNase I. The bound
protein fraction was eluted and analyzed by Western analysis. The
results suggest that the acidic domain contained in aa 239–499 of
WRN plays an essential role in binding p300 (Fig. 5D, upper
panel, lane 4), because WRN fragments lacking this region failed
to bind to p300 in this assay (lanes 3, 5 and 6). Control
experiments showed that p300 was not precipitated by GST (lane
2) and WRN GST-fusion proteins were present in similar amounts
during the binding assay (Fig. 5D, lower panel). These results
suggest that p300 specifically interacts with WRN through its
acidic domain.
To distinguish the effect of direct interaction between p300 and
WRN and that of acetylated WRN on its catalytic function, we
constructed a GST tagged-WRN fragment lacking the p300-
binding domain (WRN488–1432) (Fig. 6A). Far-Western analysis
was used to compare binding of WRN488–1432 and WRN239–499 to
p300. The results demonstrated that p300 does not bind to
WRN488–1432 (Fig. 6B, upper panel, lane 2), but it does bind to
WRN239–499 (Fig. 6B, upper panel, lane 1). Because WRN488–1432
has helicase activity but not p300 binding activity (Fig. 6C, middle
panel, lanes 2–4), it was possible to test the effect of p300
acetylation on WRN catalytic activity in the absence of p300
binding. For this experiment, purified recombinant WRN488–1432
was acetylated by p300 in the presence or absence of acetyl CoA
for 60 min at 30uC as described previously. The reaction products
were analyzed by Western analysis using an anti-GST antibody
and an anti-acetyl lysine antibody to confirm the presence of equal
amounts of WRN488–1432 and the acetylation status of WRN in
Figure 4. Acetylation of WRN increases its exonuclease activity in vivo.( A) The top panel shows a WB of 293T cell extract transfected with or
without p300 plasmid analyzed using an anti-acetyl lysine antibody; bottom panel shows the same membrane stripped and analyzed with an anti-
WRN antibody. These cell extracts were used in the measurement of WRN exonuclease activities (B). (B) Lysates from 293T cells with (lane 3) or
without (lanes 1 and 2) transfection with p300 expression plasmid were immunoprecipitated with antibodies against immunoglobulin G (IgG) (lane 1)
or WRN (lanes 2 and 3). The washed immunocomplexes were incubated with the exonuclease substrate (top, 0.5 nM, final concentration) as
described.
doi:10.1371/journal.pone.0001918.g004
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showed that p300 alone did not stimulate the helicase activity of
WRN488–1432 (Fig. 6C, middle panel, lanes 5–7). In contrast,
acetylation of WRN488–1432 by p300 did stimulate WRN helicase
activity (middle panel, lanes 8–10). Quantitative analysis of the
helicase activity of acetylated and unacetylated WRN488–1432
confirmed this conclusion (Fig. 6C, lower panel). These data
demonstrate that p300 has two separate effects on WRN function:
p300 stimulates WRN catalytic functions by binding to the
transcriptional coactivator domain, but also stimulates WRN by
acetylating the WRN488–1432 fragment. Thus, p300 appears to
play a significant role in regulating WRN catalytic activity.
Acetylation stimulates WRN DNA binding
Because the mechanism by which acetylation of WRN
stimulates its catalytic activities is unknown, we examined the
effect of acetylation on WRN DNA binding activity using a forked-
duplex substrate [30] and a gel-shift assay. The results showed that
the DNA binding activity of acetylated WRN (Fig. 7A, lanes 3 and
4) is greater than for p300 alone, without acetylation (Fig. 7A, lane
5). Furthermore, p300 alone did not stimulate DNA binding by
WRN488–1432, but acetylation of WRN488–1432 stimulated its DNA
binding activity (Fig. 7B). These results are consistent with
previous results shown above, indicating that acetylation stimulates
the catalytic activities of WRN and WRN488–1432, while p300 only
stimulates the catalytic activities of WRN (Figs. 3 and 6). These
data also suggest that the functional effects of p300 acetylation or
p300 binding on WRN are mechanistically related to increased
WRN DNA binding activity.
Acetylation regulates the role of WRN in BER
Recent studies show that WRN knockdown cells are hypersen-
sitive to MMS and have reduced short and long patch (LP) BER
activities [22]. We also demonstrated that WRN stimulates pol b
strand displacement DNA synthesis and LP BER [26] and that
acetylation of WRN increases after MMS treatment (Fig. 1). These
results suggest that acetylation may regulate the function of WRN
in BER processes in response to methylation-induced DNA
Figure 5. Characterization of the WRN/p300 physical interaction. (A) Co-immunoprecipitation of WRN and p300. HeLa nuclear extracts were
immunoprecipitated with either polyclonal rabbit anti-WRN antibodies (lane 3) or control IgG (lane 2). The immunoprecipitates were analyzed by
SDS-PAGE and Western analysis with anti-p300 or anti-WRN antibodies, as indicated. Input, 10% loaded (lane 1). (B) HeLa nuclear extracts were
immunoprecipitated with either polyclonal rabbit anti-p300 antibodies (lane 3) or control IgG (lane 1). The immunoprecipitates were probed with
anti-WRN or anti-p300 antibodies, as indicated. Input, 10% loaded (lane 2). (C) WRN and p300 were co-immunoprecipitated from HeLa nuclear
extracts either in the absence (lanes 4 and 5) or the presence (lanes 1 to 3) of ethidium bromide (Et.Br.; 50 mg/ml) with anti-WRN antibodies (lanes 2
and 5) but not with the control antibodies (lane 1), as indicated by Western analysis with anti-p300 antibodies (upper) and anti-WRN antibodies
(lower). Inputs are 10% (lanes 2 and 5). (D) HeLa nuclear extracts (400 mL) were incubated with either GST alone (lane 2) or GST-tagged WRN
fragments (lanes 3–6) that were prebound to glutathione beads. Eluted proteins were separated by SDS-PAGE, transferred to a membrane, and
stained with amido black to ensure equal loading of the various WRN fragments. The membrane was probed with mouse anti-p300 antibody. The
input (lane 1) corresponds to 5% of HeLa nuclear extracts used in the binding reactions. The asterisk indicates mobility of full-length GST-WRN
helicase domain (aa 500–946).
doi:10.1371/journal.pone.0001918.g005
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acetylated WRN on pol b strand displacement DNA synthesis
(Fig. 8). We reconstituted a BER reaction with a 34-bp substrate
containing a single nucleotide gap at position 16. Without addition
of DNA ligase, 16-mer oligonucleotide products represent
incorporation of a single [a-
32P]dCMP nucleotide and short patch
BER (Fig. 8A, lane 1). The dRP-lyase activity of pol b was inactive
on the gapped substrate used in our reconstituted strand
displacement assay, allowing us to examine the effect of WRN
acetylation on pol b DNA synthesis without interfering with the
previously reported inhibition of dRP-lyase activity of pol b after
p300 acetylation [9]. In agreement with previous results [22],
WRN stimulates pol b-catalyzed strand displacement synthesis in a
concentration-dependent manner (Fig. 8A, lanes 2–3). The results
also show that acetylation of WRN specifically stimulates
production of LP BER intermediates (2–7 nt added) (Fig. 8A,
lanes 2–5). In particular, the fraction of short patch BER
intermediates (1 nt added) was approximately 1.5-fold lower,
while the fraction of LP BER intermediates (2–7 nt added) was
approximately 2.2-fold higher in the presence of acetylated WRN
than in the presence of unacetylated WRN (Fig. 8B shows
quantification of reactions with 1 nM pol b and 12 nM WRN).
Control reactions indicate that p300 and acetyl CoA had no effect
on the strand displacement DNA synthesis of pol b (Fig. 8A, lane
8). These results suggest that acetylated WRN stimulates strand
displacement synthesis by pol b more strongly than unacetylated
WRN. We also observed that WRN and p300 stimulate strand
displacement DNA synthesis by pol b in the absence of acetyl CoA
(Fig. 8A, lanes 6–7 and 8B). However, the effect of p300 in the
absence of acetyl CoA was approximately 2-fold lower than its
effect in the presence of acetyl CoA.
To further examine the contribution of acetylated WRN or that
of acetylation in general to BER, we used a BER assay that
specifically examines pol b-mediated LP BER activity in vivo [22].
In this assay, a stable WRN shRNA knockdown (WRN KD) and
wild type cell lines (shRNA negative control), previously generated
Figure 6. Acetylation of WRN488–1432 stimulates its helicase activity. (A) A schematic representation of GST- WRN488–1432 fragment. (B)
Recombinant WRN239–499 and WRN488–1432 fragments were separated by SDS-PAGE, transferred to a membrane, and stained with amido black to
ensure equal loading of the WRN fragments (bottom panel, lanes 1 and 2). The membrane was blotted with p300 protein and probed with mouse
anti-p300 antibody (top panel, lanes 1 and 2). (C) One microgram of WRN488–1432 fragment was incubated with in the presence or absence of acetyl
CoA or p300 or both. The top panel shows Western analysis results of WRN488–1432 fragment after the acetylation assay, which was stripped and
analyzed using an anti-acetyl lysine antibody (bottom panel). These reaction mixtures were used in the measurement of helicase activity (medium
panel). Medium panel: Reactions containing increasing amounts (7.5, 15, and 30 fmol) of nonacetylated WRN488–1432 fragment (lanes 2 to 4) and
acetylated WRN488–1432 fragment (lanes 8 to 10) were incubated with a 22 bp forked substrate (0.5 nM, 22Fork3/22Fork4) for 15 min at 37uC. Lanes 5
to 7, WRN488–1432 fragment in the presence of p300. Lane 1, substrate only. Lane 11, heat-denatured substrate. Reaction products were run on a 12%
native gel and visualized using a PhosphorImager. Bottom panel: Quantitation of percentage of unwinding product.
doi:10.1371/journal.pone.0001918.g006
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have no detectable WRN expression [22]. Extracts from these cells
were incubated with a 34-bp duplex substrate containing a single
uracil residue at position 16 in a reaction containing [
32P]dCTP
and chain terminator ddGTP (Fig. 9A) to measure pol b specific
incorporation. In this assay, the first nucleotide incorporated by
pol b is [
32P]dCTP, which radiolabels the short patch BER
reaction product (Fig. 9B). When ddGTP is inserted, it terminates
DNA synthesis; thus the second nucleotide incorporated (17mer)
with ddGTP represents a LP BER product (Fig. 9B). DNA ligase,
which is present in the cell extracts, ligated some of the
radiolabeled oligonucleotides, but no reaction products containing
ddGTP could be ligated. Thus, the 34-mer ligated products are
fully repaired products of SP BER (Fig. 9B). Quantification of the
results of this assay (Fig. 9C) indicates that 25% of total BER was
LP BER in wild type cells (Fig. 9B, lane 1). In WRN KD cells, LP
BER products decreased approximately 2-fold (Fig. 9B, lanes 1
and 3), indicating that WRN stimulates pol b-mediated LP BER.
We next treated the cells with the histone deacetylase inhibitor
sodium butyrate (5 mM) for 24 h and analyzed the BER products
as described above (Fig. 9B). Sodium butyrate increases acetylation
of both histone and non-histone proteins [31,32]. In this assay we
used a 34-bp oligonucleotide duplex as a substrate (Fig. 9A), and
thus we examined the results of sodium butyrate-induced
acetylation of BER proteins rather than any influences on
chromosomal arrangements. Sodium butyrate treatment increased
the percent of LP BER synthesis of total BER by , 2-fold (Fig. 9B,
compare lanes 1 and 2). Quantitation of the 17-mer LP BER
product without including SP and ligated products showed that
sodium butyrate enhances the proportion of 17-mer LP BER
products by 1.63-fold (Fig. 9C). A concentration-dependent BER
assay using extracts from wild-type cells with or without sodium
butyrate treatment revealed that sodium butyrate increased the LP
BER intermediates at all concentrations examined (Fig. S2A).
These results suggest that sodium butyrate-induced protein
acetylation increases the pol b-mediated LP BER pathway.
WRN would be one of the acetylated proteins contributing to the
sodium butyrate stimulated LP BER since sodium butyrate was
found to increase p300 acetylation of WRN (Fig. 9D, compare lanes
1 and 2). To test the extent of WRN involvement in BER, we
measured LPBERinsodiumbutyrate treated cells lackingthe WRN
protein. In contrast to the situation in the wild type cells, LP BER
(17-mer) was not stimulated in WRN KD cells after sodium butyrate
treatment (Fig. 9B, compare lanes 3 and 4; Fig. 9C). The
quantitation of LP BER products in WRN KD cell extracts is
shown in Fig. 9C and demonstrates that sodium butyrate treatment
did not cause any significant increase in LP BER products. We
observed the same results with different cell extract concentrations
(Fig. S2B). We also explored the role of the acetylated WRN in LP
BER by using WRN proficient and the WRN KD cells after MMS
treatment, since this treatment increases the acetylation of WRN
(Fig. 1). The results demonstrated that the enhancement of pol b
strand displacement DNA synthesis after MMS treatment was
higher in WRN proficient cells than inWRN KD cells (Fig. S3A and
B). These results collectively demonstrate that cellular acetylation is
associated with an increaseinLPBER,and this increaserequires the
presence of WRN protein.
Discussion
It is proposed that WRN contributes to the maintenance of
genomic stability through its involvement in DNA repair pathways
[33]. WS cells are hypersensitive to various types of DNA
damaging agents, including H2O2, MMS, c-irradiation and
psoralen+UVA [22–25,34]. Post-translational modifications of
WRN could be an important mechanism for the regulation of
WRN functions in response to DNA damage. Acetylation is one of
Figure 7. Acetylation of WRN and WRN488–1432 stimulates their DNA binding activities. Reactions were run under the conditions described
in Materials and Methods on a 5% acrylamide gel and visualized using a PhosphorImager. (A) Acetylated WRN and WRN-p300 complex have higher
DNA binding affinity. (B) Acetylated WRN488–1432 has higher DNA binding activity.
doi:10.1371/journal.pone.0001918.g007
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DNA repair. Histone acetylation regulates chromatin assembly
facilitating access of DNA repair proteins to the sites of DNA
lesions [4]. Histone acetyltransferase, p300, can also acetylate and
interact with several DNA repair proteins; the events modulate
their activity, protein interactions and cellular localization [6–
9,35]. This study provides the first evidence that p300 acetylation
of WRN stimulates its catalytic activities in vitro and in vivo and may
play a key role in regulating its function in LP BER. Here, a
mechanistic basis for the effect of acetylation on WRN function
was characterized in detail. This study confirms an important role
for WRN in BER, and a specific role for p300 acetylation in
regulating WRN function during the course of BER.
It was previously shown that WRN participates in the repair of
MMS induced DNA base damage via both short patch and LP
BER [22,26,36]. The present study demonstrates that alkylation
damage strongly stimulates acetylation of WRN (Fig. 1), and that
acetylation of WRN by p300 stimulates its catalytic activities
(Figs. 3, 4 and 6) that stimulate pol b-mediated strand
displacement DNA synthesis and LP BER (Fig. 8 and 9).
Furthermore, treatment of wild type and WRN KD cells with
sodium butyrate stimulates LP BER in wild type cells but not in
WRN KD cells (Fig. 9). These data strongly support the ideas that
p300 acetylation of WRN is an important step in regulating BER
in cells with DNA damage.
WRN plays a role in BER during the repair of certain lesions
[22,26,36]. It can unwind several BER intermediates such as
single-strand break intermediates, and stimulate pol b strand
displacement DNA synthesis via its helicase activity [26,36]. Since
pol b does not have an intrinsic editing function, it makes frequent
Figure 8. Acetylation of WRN stimulates strand displacement DNA synthesis by Polb. (A) Reactions contained Pol b alone (1 nM) or
together with increasing concentrations of WRN (6 and 12 nM) or acetylated WRN or WRN plus p300 or p300 plus acetyl CoA. The reactions were
initiated by adding 12.5 nM one nucleotide gap substrate and were incubated for 25 minutes at 37uC, followed by analysis on a 20% denaturing gel.
(B) Quantitation of short (1 nt) and long-patch (2–6) BER intermediates.
doi:10.1371/journal.pone.0001918.g008
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domain of WRN has proofreading activity that can remove 39
mismatches following misincorporation of nucleotides by pol b,
and thus potentially enhance the fidelity of BER [38–40]. It is
likely that WRN exonuclease and helicase activities facilitate pol b
mediated strand displacement and accuracy of BER [22]. Strong
acetylation of WRN after alkylation damage might enhance the
fidelity of DNA repair synthesis.
In vitro studies with reconstituted nucleosome core particles
suggest that highly condensed chromatin inhibits some steps in
BER [41,42]. In particular, uracil DNA glycosylase (UDG) and
AP endonuclease (Ape1) activities are approximately 10-fold lower
in chromatin than in ‘‘naked’’ DNA, and pol b-catalyzed DNA
synthesis is completely inhibited by nucleosomes in vitro [41], but
DNA ligase I and Fen-1 are not inhibited by nucleosomes in vitro
[43,44]. These data suggest that pol b-catalyzed DNA synthesis
may be the rate-limiting step in BER in vivo, and that the major
point of restriction of BER in chromatin is the synthesis step of pol
b [41]. This indicates that increased acetylation might facilitate
recovery from alkylation DNA damage by two distinct comple-
menting mechanisms [4,45,46]. Firstly, acetylation of histones
might promote chromatin decondensation. Secondly, acetylation
of BER proteins, including WRN, might specifically stimulate LP
BER. The results presented here support the latter possibility,
demonstrating that WRN acetylation stimulates pol b-mediated
strand displacement DNA synthesis and LP BER (Figs. 8 and 9). It
is also possible that acetylated WRN could be more efficient to
unwind DNA at or near sites of DNA lesions. We also show that
the interaction between p300 and WRN enhances its DNA
binding. Since p300 cannot bind DNA itself [4], WRN is likely to
Figure 9. Sodium butyrate treatment enhances LP BER. Comparison of uracil-DNA mediated BER in extracts from wild-type (WT) and WRN KD
cells treated with or without 5 mM sodium butyrate. (A) Substrate DNA and predicted BER reaction products and intermediates. The sizes of
intermediates (LP BER, 2 nt addition; SN or LP BER, 1 nt addition) and complete BER (ligated 34mer SN BER) product are shown. (B) Phosphorimages of
denaturing polyacrylamide gels showing in vitro BER products. The reaction conditions and products analyses are described in Materials and
Methods. A 34 bp duplex substrate containing a uracil residue at position 16 was incubated with [
32P]dCTP and ddGTP and WT or WRN KD cell
extracts (with or without treatment with NaB), as indicated. The positions of the BER products are indicated. (C) Quantitation of LP BER products from
three different experiments is plotted. (D) Top panel: After transfection, the cells were treated with 5 mM sodium butyrate for 24 h and labeled with
0.5 mCi/ml [
3H]sodium acetate for 1 h. [
3H]acetate labeled WRN was immunoprecipitated using an anti-WRN antibody and the complex was resolved
on SDS-PAGE and analyzed by autoradiography. Lower panel: Western analysis of acetylated samples with anti-WRN antibody.
doi:10.1371/journal.pone.0001918.g009
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damaged sites, promoting chromatin remodeling. Supporting this
hypothesis, Sharma et al. showed that WRN helicase is required
for the stable recruitment of PCAF (p300/CBP-binding protein)/
P-TEFb-containing transcription complexes to DNA [47]. Thus,
while acetylation of histone and non-histone proteins may play a
general and global role in the response to DNA damage, and the
activity of other BER proteins may be downregulated or
upregulated by p300 acetylation [6–9], it is proposed here that
WRN is a key immediate downstream target of p300 acetylation,
especially in cells with alkylation DNA damage. Nevertheless,
additional experiments are needed to determine the relative
importance of acetylation of other BER proteins by p300 on the
efficiency of BER in vivo. In addition, the possibility that other
acetyltransferase activities in addition to p300 modulate BER in
vivo cannot be ruled out at this time.
Once BER is completed, WRN might be downregulated by
histone deacetylases (HDACs), which might also help reestablish
nucleosome positioning, chromatin condensation and epigenetic
programming. There are three classes of HDACs in humans: class I
and II HDACs, and the silent information regulator 2 (sir2) family
(HDAC class III) [48]. Sirtuins are nicotinamide adenine dinucle-
otide (NAD
+) dependent and are inhibited by nicotinamide [48,49],
while trichostatin A (TSA) and sodium butyrate inhibit class I and II
HDACs. Interestingly, TSA and sodium butyrate stimulate
acetylation of WRN, suggesting that class I and/or class II HDACs
deacetylate WRN in vivo. It needs to be evaluated whether sirtuins
deacetylateWRNandworktogetherwithclassIorIIHDACs.Ithas
been reported that TSA stimulated translocation of WRN from the
nucleolus into the nucleoplasm [29].
Previous studies examined the effect of sodium butyrate on
nucleotide excision repair (NER) [12–15] and double strand break
(DSB) repair [50,51]. These studies demonstrated that sodium
butyrate stimulates NER in UV-irradiated cells by inducing
chromatin hyperacetylation [12–15] and that sodium butyrate
inhibits repair of DSBs in human cancer cells by inhibiting
expression of proteins required for DSB repair including Ku70,
Ku86 and DNA-PKcs [50]. Our study is the first examination of
the effect of sodium butyrate on the cellular BER process showing
that sodium butyrate-induced acetylation stimulates LP BER in
wild type but not in cells lacking WRN. This result is consistent
with in vitro results showing that p300 acetylation of WRN
enhances pol b strand displacement DNA synthesis, and suggests
that acetylation of WRN by p300 plays a role in regulating BER,
as discussed above. The increase in LP BER after sodium butyrate
is not due to change in the pol b protein level (data not shown) or
to acetylation of pol b. Cells might have evolved a protective
mechanism to maintain WRN activity without affecting the
amount of the protein after acetylation, hereby increasing the
processivity of pol b in BER. Although it seems likely that the
effect of sodium butyrate on LP BER is mediated at least in part by
increased acetylation of WRN, it remains possible that the effect of
sodium butyrate is mediated by modulating the interaction
between WRN and other proteins involved in BER.
In conclusion, we propose that acetylated WRN may be
important for both the reorganization of chromatin structure and
for BER. WRN may recruit p300 to the damaged chromatin site
thereby supporting p300 to remodel chromatin during the BER
process. After WRN has completed its function in BER, it might
be deacetylated by class I or II HDACs, and this would facilitate
the reorganization of the chromatin structure. Thus, the genome
would remain fully functional for other metabolic processes.
Because HDACs such as Sir2 have been shown to increase life
span in certain organisms [52] and sodium butyrate and TSA
induce cellular senescence, acetylation status of WRN may also
have implications for cellular lifespan and senescence. It will be of
interest to explore this possibility in future studies.
Materials and Methods
Recombinant proteins
Recombinant histidine-tagged human WRN [53], histidine-
tagged N-WRN (amino acids 1–368), Glutathione S Transferase
(GST)-WRN fragments [54] were purified as described previously.
In vivo acetylation assay
To detect WRN acetylation in vivo, 293T cells were transfected
withWRNplasmid(3 mg) eitheralone or in combination with a p300
expression plasmid (7 mg). 48 h after transfection, the cells were
treated with 20 J/m
2 UV, 250 mMH 2O2,1 m MM M S ,c-
irradiation (6 Gy) or 0.1 mg/ml 8-methoxypsoralen+UVA and 1
mCi/ml or 0.5 mCi/ml [
3H]sodium acetate were added to the
culture for 1 h. Cells were then washed twice with cold phosphate-
buffered saline and lysed in RIPA lysis buffer (50 mM Tris-HCl (pH
7.5), 150 mM NaCl, 1 mM EDTA, 1% Triton X-100, 1 mM NaF,
1 mM sodium orthovanadate, 10 mM sodium butyrate, and a
protease inhibitor cocktail (Sigma)). The lysate was centrifuged at
14,0006g for 15 min at 4uC. Supernatants were incubated with a
rabbit anti-WRN antibody (1:50; Novus Biologicals) for 16 h at 4uC.
Each sample was then incubated with rProtein G-Agarose beads
(30 ml)at 4uCfor1 h.Immunoprecipitatedproteinswereresolved on
a 10% SDS-PAGE gel. Gels containing [
3H]acetate-labeled WRN
were first stained with Coomassie Brilliant Blue and then enhanced
by impregnating with a commercial fluorography enhancing solution
(Amplify, Amersham Biosciences) for 30 min. Dried gels were
subjected to autoradiography at 270uC for 5–7 days.
293T cells were transfected with either 50 nM siRNA sequence
against human p300 (59-GGACUACCCUAUCAAGUAAUU-39,
Dharmacon Research, Inc.) or 50 nM siControl Non-Targeting
siRNA (Dharmacon Research, Inc.) (Negative control) with or
without WRN expression plasmid (3 mg) using lipofectamine 2000
(Invitrogen, CA, USA) according to the manufacturer’s instruc-
tions. Cells were harvested 24 h after transfection and analyzed by
Western analysis with an anti-p300 antibody (C-20, Santa Cruz
Biotechnology). After p300 was silenced by siRNA, 1 mCi/ml
[
3H]sodium acetate was added to the culture for 1 h and
acetylation experiment was performed as described above.
In vitro acetylation assay
Purified recombinant WRN protein or WRN fragments (1.0 mg
each) were incubated with 100 ng of histone acetyltransferase
enzyme p300 (Jena Bioscience) in 30 ml of HAT buffer (50 mM
Tris-HCl pH 8.0, 10% glycerol (v/v), 0.1 mM EDTA, 1.0 mM
DTT, 1.0 mM PMSF, 10 mM sodium butyrate), and 0.1 mCi of
[
14C]acetyl CoA (Amersham Biosciences) at 30uC for 60 min.
Then, the reaction mixtures were subjected to SDS-PAGE
analysis. Acetylated protein was detected by autoradiography.
Gels containing [
14C]-acetate labeled proteins were fixed with
10% glacial acetic acid and 40% methanol for 70 min and were
enhanced by impregnating with a fluorography enhancing solution
(Amersham Biosciences) for 30 min. Gels were then dried and
autoradiography was performed at 270uC for 5–7 days.
In vitro GST pull-down assay from HeLa nuclear extract
The preparation of HeLa nuclear extracts (NE) and the pull
down assays with the various GST-tagged WRN fragments were
done as described previously [54]. Briefly, approximately 250 mg/
sample of HeLa NE was incubated for 3 h at 4uC with glutathione
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WRN fragments. After washing, total protein was eluted in sample
buffer by boiling and analyzed by Western blotting with mouse
monoclonal anti-p300 antibody (1:1000 dilution; BD Biosciences).
Equal loading of GST protein and the various GST-WRN
fragments were verified by amido black staining.
The catalytic activities of WRN
Helicase, ATPase and exonuclease activity assays were
conducted as previously described [55,56]. WRN was incubated
with p300 and acetyl CoA, or p300 alone or acetyl CoA alone in
HAT buffer as described above for measuring the catalytic
activities of WRN. For assays with immunocomplexes [27], rabbit
IgG (Santa Cruz Biotechnology) or rabbit anti-WRN (Novus
Biologicals) immunoprecipitates were washed three times in lysis
buffer and two times in the WRN activity reaction buffer, followed
by the addition of the exonuclease substrate. Helicase and
exonuclease products were run on 10% native and 14%
denaturing polyacrylamide gels, respectively, and ATPase samples
were analyzed on a polyethylenimine-cellulose TLC and run in
1 M formic acid-0.8 M LiCl. All the reaction products were
visualized with a PhosphorImager, and quantitated by Image-
Quant software (Amersham).
Co-immunoprecipitation assay
HeLa nuclear extracts were prepared as described previously
[54] and were pre-cleared with rProtein G-Agarose beads
(Invitrogen). Extracts (250 mg each) were incubated with either
rabbit anti-WRN antibodies (1:50; Novus Biologicals) or 5 mgo f
rabbit IgG (Santa Cruz Biotechnology) as a negative control for
16 h at 4uC. Each sample was then incubated with rProtein G-
Agarose beads (30 ml) at 4uC for 1 h. Bound proteins were eluted
by boiling in sample buffer for 5 min and analyzed by Western
analysis with mouse anti-WRN (1:250; Transduction Laboratories)
or anti-p300 (1:1000; BD Biosciences) antibodies for 16 h at 4uC
followed by chemiluminescent analysis (Pierce).
The electrophoretic mobility shift assay (EMSA)
WRN was acetylated as described above and binding reactions
(20 ml) were performed in binding buffer (40 mM Tris-HCl, pH
7.0, 1 mM EDTA, 20 mM NaCl, 8% glycerol, and 20 mg/ml
bovine serum albumin) using 30 fmol labeled DNA substrate
(34ForkA/B [30]), and WRN (0.1 pmol) or WRN488–1432
fragment (0.3 and 0.6 pmol). Protein-DNA complexes were
cross-linked by adding glutaraldehyde to reactions (0.05% final
concentration) after incubation for 15 min at 4uC and continued
to incubation for 10 min 4uC. Samples were run on 4.5%
polyacrylamide (19:1) gel and visualized using a PhosphorImager.
Far-Western blot
Far Western analysis was conducted as described previously
[57]. The recombinant GST-tagged WRN239–499 and WRN488–
1432 fragments were resolved on SDS-PAGE and blotted with
5 mg/ml p300 protein. The control blot was incubated the same
amount of BSA. Western analysis was carried out by using an anti-
p300 antibody (1:1000, BD biosciences) for 16 h at 4uC followed
by chemiluminescent analysis (Pierce).
Polymerase b incorporation assay
Reactions were done as previously described [26] with some
modifications. Briefly, reactions (10 ml) were performed in BER
buffer (50 mM HEPES, pH 7.5, 20 mM KCl, 2 mM DTT,
10 mM MgCl2) and contained 4 mM ATP, 20 mM each of dATP,
dGTP, dTTP, and 2.2 mM[ a-
32P]dCTP, and 1 nM pol b,
increasing concentrations of acetylated (as described above) or
nonacetylated WRN (6 and 12 nM). Reactions were initiated by
adding 12.5 nM 34 bp duplex oligonucleotide containing one-
nucleotide gap at position 16, and were incubated at 37uC for
25 min, followed by termination with equal volume of stop dye.
Samples were run on 20% denaturing polyacrylamide gels and
visualized using a PhosphorImager.
Cell extracts preparation and in vitro single nucleotide
and long patch BER assay
After wild-type and WRB KD cells were treated with 5 mM
sodium butyrate (NaB) (Sigma) for 24 h at 37uC, the whole cell
extracts for use in vitro BER assays were prepared as described
previously [26]. The BER assay was initiated by the addition of
treated or untreated wild-type or WRN KD whole cell extracts
(5 mg) and performed as described previously [22,26].
Supporting Information
Figure S1 WRN interacts directly with p300. Wells were coated
with p300 (3.75 nM per well). After blocking with BSA, the wells
were incubated with serial dilutions of recombinant WRN (0.47,
0.94, 1.875, 3.75, 7.5, 15, 30 and 60 nM per well) in the presence
of 10 mg/ml of ethidium bromide. Bound WRN was detected with
rabbit anti-WRN antibodies followed by colorimetric analysis.
Values represent the mean of two experiments performed in
duplicate and were corrected for the background signal (WRN
binding to BSA).
Found at: doi:10.1371/journal.pone.0001918.s001 (0.00 MB TIF)
Figure S2 (A) Upper panel: Phosphorimages of denaturing
polyacrylamide gels showing in vitro BER products of wild type
cells. Lower panel: The average fold-increase in untreated wild
type compared to NaB treated wild type cell extracts from three
different experiments is plotted. (B) Upper panel: Phosphorimages
of denaturing polyacrylamide gels showing in vitro BER products of
WRN KD cells. Lower panel: The average fold-increase in
untreated WRN KD compared to NaB treated WRN KD cell
extracts from three different experiments is plotted.
Found at: doi:10.1371/journal.pone.0001918.s002 (0.23 MB TIF)
Figure S3 Measurements of strand displacement DNA synthesis
by Polb in MMS treated or untreated WRN proficient and
WRNKD cells (A) Upper panel: A schematic of the 34-bp DNA
substrate containing a single nucleotide gap at position 16. Lower
panel: Cell extracts were prepared from treated or untreated wild
type and WRN KD cells with 1 mM MMS for 1 h. 5 mg of each
cell extract used in the assay and the reactions were initiated by
adding 12.5 nM one nucleotide gap substrate, and were incubated
for 30 minutes at 37uC. The reaction products were run on a 20%
denaturing and were visualized by a PhosphorImager. (B)
Quantitation of long-patch (2–19 nt) BER intermediates in cell
extracts treated with/without MMS.
Found at: doi:10.1371/journal.pone.0001918.s003 (0.32 MB TIF)
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